Diabetes Management in Chronic Kidney Disease: Synopsis of the 2020 KDIGO Clinical Practice Guideline

The Kidney Disease: Improving Global Outcomes (KDIGO) organization developed a clinical practice guideline in 2020 for the management of patients with diabetes and chronic kidney disease (CKD). The KDIGO Work Group (WG) was tasked with developing the guideline for diabetes management in CKD. It defi...

Full description

Saved in:

Bibliographic Details
Published in:	Annals of internal medicine Vol. 174; no. 3; p. 385
Main Authors:	Navaneethan, Sankar D, Zoungas, Sophia, Caramori, M Luiza, Chan, Juliana C N, Heerspink, Hiddo J L, Hurst, Clint, Liew, Adrian, Michos, Erin D, Olowu, Wasiu A, Sadusky, Tami, Tandon, Nikhil, Tuttle, Katherine R, Wanner, Christoph, Wilkens, Katy G, Lytvyn, Lyubov, Craig, Jonathan C, Tunnicliffe, David J, Howell, Martin, Tonelli, Marcello, Cheung, Michael, Earley, Amy, Rossing, Peter, de Boer, Ian H, Khunti, Kamlesh
Format:	Journal Article
Language:	English
Published:	United States 01.03.2021
Subjects:	Diabetes Mellitus, Type 1 - complications Diabetes Mellitus, Type 1 - therapy Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - therapy Humans Renal Insufficiency, Chronic - complications Renal Insufficiency, Chronic - therapy
ISSN:	1539-3704, 1539-3704
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Abstract	The Kidney Disease: Improving Global Outcomes (KDIGO) organization developed a clinical practice guideline in 2020 for the management of patients with diabetes and chronic kidney disease (CKD). The KDIGO Work Group (WG) was tasked with developing the guideline for diabetes management in CKD. It defined the scope of the guideline, gathered evidence, determined systematic review topics, and graded evidence that had been summarized by an evidence review team. The English-language literature searches, which were initially done through October 2018, were updated in February 2020. The WG used the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach to appraise evidence and rate the strength of the recommendations. Expert judgment was used to develop consensus practice points supplementary to the evidence-based graded recommendations. The guideline document underwent open public review. Comments from various stakeholders, subject matter experts, and industry and national organizations were considered before the document was finalized. The guideline includes 12 recommendations and 48 practice points for clinicians caring for patients with diabetes and CKD. This synopsis focuses on the key recommendations pertinent to the following issues: comprehensive care needs, glycemic monitoring and targets, lifestyle interventions, antihyperglycemic therapies, and educational and integrated care approaches.
AbstractList	The Kidney Disease: Improving Global Outcomes (KDIGO) organization developed a clinical practice guideline in 2020 for the management of patients with diabetes and chronic kidney disease (CKD).DESCRIPTIONThe Kidney Disease: Improving Global Outcomes (KDIGO) organization developed a clinical practice guideline in 2020 for the management of patients with diabetes and chronic kidney disease (CKD).The KDIGO Work Group (WG) was tasked with developing the guideline for diabetes management in CKD. It defined the scope of the guideline, gathered evidence, determined systematic review topics, and graded evidence that had been summarized by an evidence review team. The English-language literature searches, which were initially done through October 2018, were updated in February 2020. The WG used the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach to appraise evidence and rate the strength of the recommendations. Expert judgment was used to develop consensus practice points supplementary to the evidence-based graded recommendations. The guideline document underwent open public review. Comments from various stakeholders, subject matter experts, and industry and national organizations were considered before the document was finalized.METHODSThe KDIGO Work Group (WG) was tasked with developing the guideline for diabetes management in CKD. It defined the scope of the guideline, gathered evidence, determined systematic review topics, and graded evidence that had been summarized by an evidence review team. The English-language literature searches, which were initially done through October 2018, were updated in February 2020. The WG used the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach to appraise evidence and rate the strength of the recommendations. Expert judgment was used to develop consensus practice points supplementary to the evidence-based graded recommendations. The guideline document underwent open public review. Comments from various stakeholders, subject matter experts, and industry and national organizations were considered before the document was finalized.The guideline includes 12 recommendations and 48 practice points for clinicians caring for patients with diabetes and CKD. This synopsis focuses on the key recommendations pertinent to the following issues: comprehensive care needs, glycemic monitoring and targets, lifestyle interventions, antihyperglycemic therapies, and educational and integrated care approaches.RECOMMENDATIONSThe guideline includes 12 recommendations and 48 practice points for clinicians caring for patients with diabetes and CKD. This synopsis focuses on the key recommendations pertinent to the following issues: comprehensive care needs, glycemic monitoring and targets, lifestyle interventions, antihyperglycemic therapies, and educational and integrated care approaches. The Kidney Disease: Improving Global Outcomes (KDIGO) organization developed a clinical practice guideline in 2020 for the management of patients with diabetes and chronic kidney disease (CKD). The KDIGO Work Group (WG) was tasked with developing the guideline for diabetes management in CKD. It defined the scope of the guideline, gathered evidence, determined systematic review topics, and graded evidence that had been summarized by an evidence review team. The English-language literature searches, which were initially done through October 2018, were updated in February 2020. The WG used the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach to appraise evidence and rate the strength of the recommendations. Expert judgment was used to develop consensus practice points supplementary to the evidence-based graded recommendations. The guideline document underwent open public review. Comments from various stakeholders, subject matter experts, and industry and national organizations were considered before the document was finalized. The guideline includes 12 recommendations and 48 practice points for clinicians caring for patients with diabetes and CKD. This synopsis focuses on the key recommendations pertinent to the following issues: comprehensive care needs, glycemic monitoring and targets, lifestyle interventions, antihyperglycemic therapies, and educational and integrated care approaches.
Author	Wanner, Christoph Heerspink, Hiddo J L Sadusky, Tami Lytvyn, Lyubov Howell, Martin Zoungas, Sophia Olowu, Wasiu A Tonelli, Marcello Chan, Juliana C N Khunti, Kamlesh Hurst, Clint de Boer, Ian H Caramori, M Luiza Tandon, Nikhil Tunnicliffe, David J Earley, Amy Wilkens, Katy G Cheung, Michael Tuttle, Katherine R Michos, Erin D Craig, Jonathan C Liew, Adrian Rossing, Peter Navaneethan, Sankar D
Author_xml	– sequence: 1 givenname: Sankar D surname: Navaneethan fullname: Navaneethan, Sankar D organization: Section of Nephrology and Institute of Clinical and Translational Research, Baylor College of Medicine, and Michael E. DeBakey VA Medical Center, Houston, Texas (S.D.N.) – sequence: 2 givenname: Sophia orcidid: 0000-0003-2672-0949 surname: Zoungas fullname: Zoungas, Sophia organization: Monash University, School of Public Health and Preventive Medicine, Melbourne, Victoria, Australia (S.Z.) – sequence: 3 givenname: M Luiza surname: Caramori fullname: Caramori, M Luiza organization: University of Minnesota, Minneapolis, Minnesota (M.L.C.) – sequence: 4 givenname: Juliana C N orcidid: 0000-0003-1325-1194 surname: Chan fullname: Chan, Juliana C N organization: Hong Kong Institute of Diabetes and Obesity and Li Ka Shing Institute of Health Science, The Chinese University of Hong Kong, Hong Kong, China (J.C.C.) – sequence: 5 givenname: Hiddo J L orcidid: 0000-0002-3126-3730 surname: Heerspink fullname: Heerspink, Hiddo J L organization: University of Groningen and University Medical Center, Groningen, the Netherlands (H.J.H.) – sequence: 6 givenname: Clint surname: Hurst fullname: Hurst, Clint organization: Houston, Texas (C.H.) – sequence: 7 givenname: Adrian orcidid: 0000-0002-0963-6270 surname: Liew fullname: Liew, Adrian organization: Mount Elizabeth Novena Hospital, Singapore (A.L.) – sequence: 8 givenname: Erin D orcidid: 0000-0002-5547-5084 surname: Michos fullname: Michos, Erin D organization: Johns Hopkins University School of Medicine, Baltimore, Maryland (E.D.M.) – sequence: 9 givenname: Wasiu A surname: Olowu fullname: Olowu, Wasiu A organization: Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Osun, Nigeria (W.A.O.) – sequence: 10 givenname: Tami surname: Sadusky fullname: Sadusky, Tami organization: Seattle, Washington (T.S.) – sequence: 11 givenname: Nikhil orcidid: 0000-0003-4604-1986 surname: Tandon fullname: Tandon, Nikhil organization: All India Institute of Medical Sciences, New Delhi, India (N.T.) – sequence: 12 givenname: Katherine R orcidid: 0000-0002-2235-0103 surname: Tuttle fullname: Tuttle, Katherine R organization: University of Washington, Spokane, Washington (K.R.T.) – sequence: 13 givenname: Christoph surname: Wanner fullname: Wanner, Christoph organization: University Hospital of Würzburg, Würzburg, Germany (C.W.) – sequence: 14 givenname: Katy G orcidid: 0000-0002-1281-4541 surname: Wilkens fullname: Wilkens, Katy G organization: Northwest Kidney Centers, Seattle, Washington (K.G.W.) – sequence: 15 givenname: Lyubov surname: Lytvyn fullname: Lytvyn, Lyubov organization: MAGIC Evidence Ecosystem Foundation, McMaster University, Hamilton, Ontario, Canada (L.L.) – sequence: 16 givenname: Jonathan C surname: Craig fullname: Craig, Jonathan C organization: College of Medicine and Public Health, Flinders University, and Cochrane Kidney and Transplant, Adelaide, Australia (J.C.C.) – sequence: 17 givenname: David J surname: Tunnicliffe fullname: Tunnicliffe, David J organization: School of Public Health, The University of Sydney, and Cochrane Kidney and Transplant, Sydney, Australia (D.J.T., M.H.) – sequence: 18 givenname: Martin surname: Howell fullname: Howell, Martin organization: School of Public Health, The University of Sydney, and Cochrane Kidney and Transplant, Sydney, Australia (D.J.T., M.H.) – sequence: 19 givenname: Marcello orcidid: 0000-0002-0846-3187 surname: Tonelli fullname: Tonelli, Marcello organization: University of Calgary, Calgary, Alberta, Canada (M.T.) – sequence: 20 givenname: Michael surname: Cheung fullname: Cheung, Michael organization: KDIGO, Brussels, Belgium (M.C., A.E.) – sequence: 21 givenname: Amy orcidid: 0000-0003-3200-2492 surname: Earley fullname: Earley, Amy organization: KDIGO, Brussels, Belgium (M.C., A.E.) – sequence: 22 givenname: Peter orcidid: 0000-0002-1531-4294 surname: Rossing fullname: Rossing, Peter organization: Steno Diabetes Center and University of Copenhagen, Copenhagen, Denmark (P.R.) – sequence: 23 givenname: Ian H orcidid: 0000-0003-1571-7592 surname: de Boer fullname: de Boer, Ian H organization: University of Washington, Kidney Research Institute, Seattle, Washington (I.H.D.) – sequence: 24 givenname: Kamlesh surname: Khunti fullname: Khunti, Kamlesh organization: Diabetes Research Centre, University of Leicester, and Leicester General Hospital, Leicester, United Kingdom (K.K.)
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/33166222$$D View this record in MEDLINE/PubMed
BookMark	eNpNUF9LwzAcDDJxWxX8BJJHX6r506aZb9JpHduYoD6XNPnFRdp0Nu3Dvr0FJ_h0x3F3cDdHE996QOiakruMM3G_ZSROF1yeoRlN-SLmGUkm__gUzUP4IoRwyeQFmnJOhWCMzRAsnaqgh4C3yqtPaMD32Hmc77vWO43Xzng44qULoAI84Lejbw_BBdxa3O8BM8IIXi9XxQ7ntRsTqsavndK904CLwRkYVbhE51bVAa5OGKGP56f3_CXe7IpV_riJdUJpH4tEWE1kYqkigovMVNIAhcQwbqt05CLjmhBrtJZGWi00qbTOJLAkpYZYFqHb395D134PEPqycUFDXSsP7RDK0bfgaZqN2yN0c7IOVQOmPHSuUd2x_LuG_QC6KmUP
CitedBy_id	crossref_primary_10_1016_j_kint_2022_10_030 crossref_primary_10_3389_fphar_2024_1468435 crossref_primary_10_3390_ph15040442 crossref_primary_10_1016_j_intimp_2024_111954 crossref_primary_10_1016_j_lansea_2022_100062 crossref_primary_10_3390_jcm11185259 crossref_primary_10_1111_jch_14186 crossref_primary_10_1080_0886022X_2023_2195950 crossref_primary_10_3389_fendo_2022_869899 crossref_primary_10_1016_j_jcjd_2023_04_006 crossref_primary_10_4103_NJM_NJM_95_22 crossref_primary_10_1001_jamanetworkopen_2022_1169 crossref_primary_10_1016_j_phrs_2023_106710 crossref_primary_10_3389_fphar_2024_1349069 crossref_primary_10_1161_JAHA_122_026289 crossref_primary_10_7759_cureus_80495 crossref_primary_10_1051_bioconf_20236001009 crossref_primary_10_1038_s41598_022_22932_4 crossref_primary_10_1186_s12874_022_01701_x crossref_primary_10_1177_01410768211011109 crossref_primary_10_3389_fphar_2022_782199 crossref_primary_10_1016_j_metabol_2021_154961 crossref_primary_10_2215_CJN_18771220 crossref_primary_10_1186_s12882_022_02885_6 crossref_primary_10_1080_14728222_2022_2133698 crossref_primary_10_7326_M22_3635 crossref_primary_10_1016_j_jacadv_2024_101131 crossref_primary_10_1007_s13410_024_01348_y crossref_primary_10_3390_ijerph19159010 crossref_primary_10_3389_fphar_2022_996042 crossref_primary_10_1371_journal_pone_0314029 crossref_primary_10_1186_s12902_025_01853_z crossref_primary_10_1016_j_imu_2025_101685 crossref_primary_10_1016_j_pharma_2022_05_003 crossref_primary_10_1111_dme_15460 crossref_primary_10_1007_s00108_023_01482_5 crossref_primary_10_1111_dom_16394 crossref_primary_10_1136_bmjdrc_2022_003201 crossref_primary_10_1002_jbt_23445 crossref_primary_10_1016_j_diabres_2021_109043 crossref_primary_10_1053_j_akdh_2023_07_004 crossref_primary_10_1097_MD_0000000000032489 crossref_primary_10_9778_cmajo_20210281 crossref_primary_10_1016_j_diabres_2023_110693 crossref_primary_10_1016_j_diabres_2023_110576 crossref_primary_10_4103_ijem_ijem_377_23 crossref_primary_10_1016_j_amjmed_2022_04_015 crossref_primary_10_1016_j_ecoenv_2023_115829 crossref_primary_10_1007_s11897_022_00573_y crossref_primary_10_1053_j_jrn_2025_06_002 crossref_primary_10_2215_CJN_04510422 crossref_primary_10_1016_j_lanwpc_2022_100509 crossref_primary_10_1097_MNH_0000000000000976 crossref_primary_10_1159_000528021 crossref_primary_10_1080_0886022X_2022_2160347 crossref_primary_10_1111_dme_15038 crossref_primary_10_3389_fcimb_2022_1046373 crossref_primary_10_1186_s12882_022_02717_7 crossref_primary_10_3390_jcm10132943 crossref_primary_10_1111_dom_15200 crossref_primary_10_1097_MNH_0000000000000727 crossref_primary_10_1016_j_bonr_2024_101774 crossref_primary_10_1097_MD_0000000000025759 crossref_primary_10_1053_j_jrn_2023_12_004 crossref_primary_10_1038_s41598_023_38251_1 crossref_primary_10_34067_KID_0000000000000396 crossref_primary_10_1177_20406223231214641 crossref_primary_10_3390_jcm12020691 crossref_primary_10_1016_j_kint_2020_11_021 crossref_primary_10_1016_j_ymthe_2021_10_013 crossref_primary_10_1097_MD_0000000000035618 crossref_primary_10_3389_fendo_2022_941215 crossref_primary_10_1136_bmjoq_2022_002032 crossref_primary_10_3389_fpubh_2022_952899 crossref_primary_10_1016_j_japh_2023_06_003 crossref_primary_10_1097_CM9_0000000000002046 crossref_primary_10_7326_ANNALS_24_01449 crossref_primary_10_1016_j_bcp_2022_115407 crossref_primary_10_1016_j_amjcard_2022_02_013 crossref_primary_10_1371_journal_pone_0268871 crossref_primary_10_1186_s12889_025_21639_1 crossref_primary_10_1186_s12882_025_04172_6 crossref_primary_10_4330_wjc_v13_i12_676 crossref_primary_10_1111_dom_15700 crossref_primary_10_2147_DMSO_S477836 crossref_primary_10_1002_ptr_7756 crossref_primary_10_1109_ACCESS_2024_3451369 crossref_primary_10_1177_19322968241292041 crossref_primary_10_1681_ASN_2022020147 crossref_primary_10_1016_j_diabres_2022_110118 crossref_primary_10_1038_s41598_025_98641_5 crossref_primary_10_1007_s13300_021_01059_1 crossref_primary_10_3390_ph15091140 crossref_primary_10_1155_2023_9663320 crossref_primary_10_3390_molecules27196221 crossref_primary_10_1016_j_dsx_2024_103037 crossref_primary_10_1210_clinem_dgad144 crossref_primary_10_1097_MNH_0000000000000814 crossref_primary_10_1097_MNH_0000000000000811 crossref_primary_10_34067_KID_0000000000000089
ContentType	Journal Article
DBID	CGR CUY CVF ECM EIF NPM 7X8
DOI	10.7326/M20-5938
DatabaseName	Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic
DatabaseTitle	MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic MEDLINE
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	no_fulltext_linktorsrc
Discipline	Medicine
EISSN	1539-3704
ExternalDocumentID	33166222
Genre	Research Support, Non-U.S. Gov't Journal Article Practice Guideline
GroupedDBID	--- ..I .55 .GJ .XZ 08G 1CY 23M 2WC 354 36B 39C 3O- 3V. 4.4 53G 5GY 5RE 5RS 6J9 7RV 7X7 88E 8C1 8F7 8FI 8FJ 8G5 8R4 8R5 AAKAS AAQOH AAQQT AARDX AAWTL AAYOK ABBLC ABCQX ABDPE ABJNI ABOCM ABPMR ABUWG ACBNA ACGFO ACGFS ADBBV ADZCM AEGXH AENEX AERZD AFCHL AFFNX AFKRA AHJKT AHMBA AI. AIAGR ALIPV ALMA_UNASSIGNED_HOLDINGS AQUVI ASPBG AVWKF AZFZN AZQEC BCR BCU BEC BENPR BKEYQ BKNYI BLC BPHCQ BTJBQ BVXVI BZLQD C1A C45 CCPQU CGR CUY CVF DWQXO E3Z EBS ECM EIF EJD EMB EMOBN EX3 F5P FEDTE FYUFA GNUQQ GUQSH H13 HMCUK HVGLF H~9 IH2 J5H K-O K9- L7B LPU M0R M0T M1P M2O M5~ MV1 MVM N4W NAPCQ NPM OBH OCB OFXIZ OGEVE OHH OHT OVD OVIDX P2P PCD PQQKQ PROAC PSQYO Q2X RWL RXW S0X SJFOW SJN SV3 TAE TEORI TPH TR2 TWZ UKHRP UKR VH1 VVN VXZ WH7 WOQ WOW X6Y X7M XOL YFH YOC YQJ YYP ZGI ZXP ZY1 ~H1 7X8
ID	FETCH-LOGICAL-c411t-646fc084f1a06367db8de1e4d23fb58de673c00fdcc8d8fc6c0bcc78e2451d0f2
IEDL.DBID	7X8
ISICitedReferencesCount	120
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000629294000021&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1539-3704
IngestDate	Fri Sep 05 07:44:53 EDT 2025 Wed Feb 19 02:29:14 EST 2025
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	3
Language	English
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c411t-646fc084f1a06367db8de1e4d23fb58de673c00fdcc8d8fc6c0bcc78e2451d0f2
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Instructional Material/Guideline-3 content type line 23
ORCID	0000-0003-1571-7592 0000-0002-0963-6270 0000-0003-4604-1986 0000-0002-2235-0103 0000-0002-0846-3187 0000-0003-1325-1194 0000-0003-3200-2492 0000-0003-2672-0949 0000-0002-1281-4541 0000-0002-5547-5084 0000-0002-1531-4294 0000-0002-3126-3730
OpenAccessLink	https://pure.rug.nl/ws/files/177480198/m20_5938.pdf
PMID	33166222
PQID	2459355762
PQPubID	23479
ParticipantIDs	proquest_miscellaneous_2459355762 pubmed_primary_33166222
PublicationCentury	2000
PublicationDate	2021-03-00 20210301
PublicationDateYYYYMMDD	2021-03-01
PublicationDate_xml	– month: 03 year: 2021 text: 2021-03-00
PublicationDecade	2020
PublicationPlace	United States
PublicationPlace_xml	– name: United States
PublicationTitle	Annals of internal medicine
PublicationTitleAlternate	Ann Intern Med
PublicationYear	2021
References	33646846 - Ann Intern Med. 2021 Mar;174(3):JC26
References_xml	– reference: 33646846 - Ann Intern Med. 2021 Mar;174(3):JC26
SSID	ssj0003828
Score	2.651543
SecondaryResourceType	review_article
Snippet	The Kidney Disease: Improving Global Outcomes (KDIGO) organization developed a clinical practice guideline in 2020 for the management of patients with diabetes...
SourceID	proquest pubmed
SourceType	Aggregation Database Index Database
StartPage	385
SubjectTerms	Diabetes Mellitus, Type 1 - complications Diabetes Mellitus, Type 1 - therapy Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - therapy Humans Renal Insufficiency, Chronic - complications Renal Insufficiency, Chronic - therapy
Title	Diabetes Management in Chronic Kidney Disease: Synopsis of the 2020 KDIGO Clinical Practice Guideline
URI	https://www.ncbi.nlm.nih.gov/pubmed/33166222 https://www.proquest.com/docview/2459355762
Volume	174
WOSCitedRecordID	wos000629294000021&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings	1
isFullTextHit
isPrint
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwFA7qRHzxfpk3Ivha1jRpk_ki4tyUsTlQYW-juUFB2mk3Yf_ekzZjT4LgS-hLkzY9J-dLztfvIHQDMZdK3o4DwKJhwBzNVRLYrAAUYVxBI2JZFZvgw6EYj9sjf-BWelrlck2sFmpdKHdG3opY7KTAwXfvpp-Bqxrlsqu-hMY6alCAMo7SxccrtXAqqtqq4NRtcKSQ1eKzHBBLawC7JuhQ_A4sqwDT3f3vo-2hHQ8t8X1tC_tozeQHaGvgk-eHyHj2S4lXnBec5djr4-J-pnOzwJ06ZXOLXxd5MS2zEhcWA0zEEWA-3O88916wVxP9wCP_kxXuzZ1eFoxzhN67j28PT4GvshAoRsgsSFhiVSiYJSnAlYRrKbQhhumIWhnDdcKpCkOrlRJaWJWoUCrFhYHXJjq00THayIvcnCKsNQS3yFJLrGSpYinjkU0lT4VMSUrCJrpeTuAErNilJtLcFPNysprCJjqpv8JkWsttTCglSQIw5uwPd5-j7ciRTiqS2AVqWPBhc4k21fcsK7-uKvOAdjga_ACvFsOY
linkProvider	ProQuest
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diabetes+Management+in+Chronic+Kidney+Disease%3A+Synopsis+of+the+2020+KDIGO+Clinical+Practice+Guideline&rft.jtitle=Annals+of+internal+medicine&rft.au=Navaneethan%2C+Sankar+D&rft.au=Zoungas%2C+Sophia&rft.au=Caramori%2C+M+Luiza&rft.au=Chan%2C+Juliana+C+N&rft.date=2021-03-01&rft.issn=1539-3704&rft.eissn=1539-3704&rft.volume=174&rft.issue=3&rft.spage=385&rft_id=info:doi/10.7326%2FM20-5938&rft.externalDBID=NO_FULL_TEXT
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1539-3704&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1539-3704&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1539-3704&client=summon